IVHD-valtrate
Product Specifications
UNSPSC Description
IVHD-valtrate, an active Valeriana jatamansi derivative, is against human ovarian cancer cells in vitro and in vivo. IVHD-valtrate induces cancer cells apoptosis and arrests the ovarian cancer cells in the G2/M phase. IVHD-valtrate has the potential to be a novel chemotherapeutic agent for the human ovarian cancer research[1].
Target Antigen
Apoptosis
Type
Natural Products
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ivhd-valtrate.html
Solubility
10 mM in DMSO
Smiles
CC(O[C@@H](C1)[C@]2(CO2)[C@]([C@@H]3OC(CC(C)C)=O)([H])[C@]1(C(COC(C(C(C)C)OC(CC(C)C)=O)=O)=CO3)O)=O
Molecular Weight
540.60
References & Citations
[1]Xiaoguang Li, et al. Valeriana jatamansi constituent IVHD-valtrate as a novel therapeutic agent to human ovarian cancer: in vitro and in vivo activities and mechanisms. Curr Cancer Drug Targets. 2013 May;13(4):472-83.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-N3446/IVHD-valtrate-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-N3446/
Clinical Information
No Development Reported
CAS Number
28325-56-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6210114-01 0.1 mL
ADRA1A (Alpha-1A Adrenergic Receptor, Alpha-1A Adrenoreceptor, Alpha-1A Adrenoceptor, Alpha-1C Adrenergic Receptor, Alpha-adrenergic Receptor 1c, ADRA1C) (MaxLight 550)
Ask
View Details 
MBS6210114-02 5x 0.1 mL
ADRA1A (Alpha-1A Adrenergic Receptor, Alpha-1A Adrenoreceptor, Alpha-1A Adrenoceptor, Alpha-1C Adrenergic Receptor, Alpha-adrenergic Receptor 1c, ADRA1C) (MaxLight 550)
Ask
View Details